Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Ann Pharmacother ; 45(7-8): 967-76, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21775694

ABSTRACT

OBJECTIVE: To review the literature concerning the role of rifampin in the combination treatment of Legionella pneumophila pneumonia. DATA SOURCES: A search of MEDLINE and Ovid databases was conducted (January 1970-May 2011) using the search terms Legionella pneumophila, pneumonia, Legionnaires' disease, rifampin or rifampicin, macrolide, fluoroquinolone, erythromycin, clarithromycin, levofloxacin, ciprofloxacin, and moxifloxacin STUDY SELECTION AND DATA EXTRACTION: In vivo studies published in English that compared antimicrobial therapies including rifampin for the treatment of Legionella pneumonia, as well as in vitro studies including an assessment of rifampin bioactivity, were included. DATA SYNTHESIS: Macrolides and fluoroquinolones have been effective as monotherapy in the treatment of L. pneumophila pneumonia. This review includes evidence summaries from 4 bioactivity evaluations, 6 clinical studies, and 6 reported cases of combination rifampin use. Combined with supporting evidence, the role of combination rifampin therapy is further delineated. CONCLUSIONS: Interpretation of the data is limited by the potential for selection bias and lack of consistent comparators. Rifampin therapy should be considered only for patients with severe disease or significant comorbid conditions (eg, uncontrolled diabetes, smoking, or obstructive lung disease) including immunocompromised hosts and those refractory to conventional monotherapy regimens. Caution for significant adverse drug events and drug-drug interactions should be taken with the addition of rifampin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Legionella pneumophila/drug effects , Legionnaires' Disease/drug therapy , Nucleic Acid Synthesis Inhibitors/therapeutic use , Rifampin/therapeutic use , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/pharmacokinetics , Drug Interactions , Drug Resistance, Multiple, Bacterial , Drug Therapy, Combination/adverse effects , Humans , Legionnaires' Disease/complications , Legionnaires' Disease/metabolism , Nucleic Acid Synthesis Inhibitors/adverse effects , Nucleic Acid Synthesis Inhibitors/pharmacokinetics , Rifampin/adverse effects , Rifampin/pharmacokinetics , Severity of Illness Index
2.
Am J Pharm Educ ; 75(1): 9, 2011 Feb 10.
Article in English | MEDLINE | ID: mdl-21451761

ABSTRACT

OBJECTIVE: To implement and evaluate the impact of an elective evidence-based medicine (EBM) course on student performance during advanced pharmacy practice experiences (APPEs). DESIGN: A 2-hour elective course was implemented using active-learning techniques including case studies and problem-based learning, journal club simulations, and student-driven wiki pages. The small class size (15 students) encouraged independent student learning, allowing students to serve as the instructors and guest faculty members from a variety of disciplines to facilitate discussions. ASSESSMENT: Pre- and posttests found that students improved on 83% of the core evidence-based medicine concepts evaluated. Fifty-four APPE preceptors were surveyed to compare the performance of students who had completed the EBM course prior to starting their APPEs with students who had not. Of the 38 (70%) who responded, the majority (86.9%) agreed that students who had completed the course had stronger skills in applying evidence-based medicine to patient care than other students. The 14 students who completed the elective also were surveyed after completing their APPEs and the 11 who responded agreed the class had improved their skills and provided confidence in using the medical literature. CONCLUSIONS: The skill set acquired from this EBM course improved students' performance in APPEs. Evidence-based medicine and literature search skills should receive more emphasis in the pharmacy curriculum.


Subject(s)
Education, Pharmacy/methods , Evidence-Based Medicine , Students, Pharmacy , Clinical Competence , Educational Measurement , Humans , Patient Care/methods , Pharmaceutical Services/organization & administration , Preceptorship , Problem-Based Learning
3.
Ann Pharmacother ; 44(12): 2001-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21119097

ABSTRACT

OBJECTIVE: To report 3 successful treatments of vancomycin-resistant Enterococcus faecium meningitis in adults using daptomycin and either linezolid or gentamicin. CASE SUMMARY: Three case reports involving males (aged 58-78 years) are presented; in each case (trigeminal nerve microvascular decompression and subdural hygroma; paraspinal abscess; and hydrocephalus with subsequent craniotomy and ventriculo-peritoneal shunt placement) CSF examination revealed vancomycin-resistant Enterococcus (VRE) susceptible to daptomycin, gentamicin, and/or linezolid. Threeto four-week treatment regimens with daptomycin 6-12 mg/kg and either gentamicin or linezolid led to clinical resolution and microbiological clearance of infection. DISCUSSION: Daptomycin has previously been shown to be successful in treating methicillin-resistant Staphylococcus aureus-associated meningitis and other serious VRE and enterococcal infections. Higher than approved doses of daptomycin were used in 2 cases where in theory higher CSF concentrations would thus be obtained. Gentamicin and linezolid were added to daptomycin therapy based on in vitro data synergy results and because of documented successful treatment for VRE meningitis, respectively. CONCLUSIONS: The difficulty in treating VRE CSF infections involves both drug kinetics and microbial resistance factors, as well as external factors such as foreign bodies like shunts. This report highlighted 3 cases where daptomycin use in concert with either gentamicin or linezolid was successful in treating this infection. Additional controlled trials will be helpful in identifying the best strategies when using daptomycin to treat CSF infections.


Subject(s)
Acetamides/therapeutic use , Daptomycin/therapeutic use , Enterococcus faecium/drug effects , Gentamicins/therapeutic use , Gram-Positive Bacterial Infections/drug therapy , Meningitis, Bacterial/drug therapy , Oxazolidinones/therapeutic use , Vancomycin/pharmacology , Acetamides/administration & dosage , Aged , Daptomycin/administration & dosage , Drug Therapy, Combination , Gentamicins/administration & dosage , Humans , Linezolid , Male , Meningitis, Bacterial/microbiology , Middle Aged , Oxazolidinones/administration & dosage , Vancomycin Resistance/drug effects
4.
Ann Pharmacother ; 44(11): 1739-46, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20959503

ABSTRACT

BACKGROUND: Nighttime and weekend admission has been associated with increased morbidity and mortality and has been linked to a variety of factors. Medication errors in hospitalized patients occur frequently, but the association between error rates and time of day and day of week (weekday vs weekend) has not been extensively studied. OBJECTIVE: To compare reported medication error rates over a 1-year period between daytime versus nighttime shifts and weekday versus weekend in a children's hospital and to characterize the types of errors that occurred. METHODS: One hundred forty errors reported between January and December 2008 were retrospectively reviewed and classified by error type and severity according to established standards. Two investigators independently classified errors, and a third investigator with pediatric pharmacy expertise resolved discrepancies. Data on doses dispensed were collected from pharmacy records. RESULTS: Over the study period, the reported error rate during daytime nursing shifts was 1.17 errors per 1000 doses dispensed versus 2.12 errors per 1000 doses dispensed for nighttime nursing shifts (p = 0.005). The error rates during pharmacy shifts (1st, 2nd, and 3rd) were 1.01, 2.24, and 1.88 per 1000 doses dispensed, respectively (p = 0.0019). Reported errors for weekday versus weekend were 1.9 errors per 1000 weekday doses versus 2.55 errors per 1000 doses, respectively (p = 0.181), and error rate for weekend shifts relative to first shift on weekdays was greater (p = 0.0004). Errors in medication administration, followed by dispensing errors, occurred most frequently. CONCLUSIONS: There was an increase in medication error rate during evening and nighttime shifts relative to day shift and during weekends relative to weekdays at this institution. Additional studies to validate this finding are needed; however, error prevention efforts should be instituted now for evening, nighttime, and weekend medication dispensing and administration.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Hospitals, Pediatric/statistics & numerical data , Medication Errors/statistics & numerical data , Personnel Staffing and Scheduling/statistics & numerical data , Child , Hospitalization/statistics & numerical data , Humans , Nursing Staff, Hospital/standards , Nursing Staff, Hospital/statistics & numerical data , Pharmacy Service, Hospital/standards , Pharmacy Service, Hospital/statistics & numerical data , Retrospective Studies , Severity of Illness Index , Time Factors
5.
Ann Pharmacother ; 44(11): 1832-5, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20959502

ABSTRACT

OBJECTIVE: To report a case of methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia with suspected MSSA meningitis treated with high-dose daptomycin assessed with concurrent serum and cerebrospinal fluid (CSF) concentrations. CASE SUMMARY: A 54-year-old male presented to the emergency department with generalized weakness and presumed health-care-associated pneumonia shown on chest radiograph. Treatment was empirically initiated with vancomycin, levofloxacin, and piperacillin/tazobactam. Blood cultures revealed S. aureus susceptible to oxacillin. Empiric antibiotic treatment was narrowed to nafcillin on day 4. On day 8, the patient developed acute renal failure (serum creatinine 1.9 mg/dL, increased from 1.2 mg/dL the previous day and 0.8 mg/dL on admission). The patient's Glasgow Coma Score was 3, with normal findings shown on computed tomography scan of the head 72 hours following an episode of cardiac arrest on day 10. The patient experienced relapsing MSSA bacteremia on day 9, increasing the suspicion for a central nervous system (CNS) infection. Nafcillin was discontinued and daptomycin 9 mg/kg daily was initiated for suspected meningitis and was continued until the patient's death on day 16. Daptomycin serum and CSF trough concentrations were 11.21 µg/mL and 0.52 µg/mL, respectively, prior to the third dose. Lumbar puncture results were inconclusive and no further blood cultures were positive for MSSA. Creatine kinase levels were normal prior to daptomycin therapy and were not reassessed. DISCUSSION: Daptomycin was initiated in our patient secondary to possible nafcillin-induced acute interstitial nephritis and relapsing bacteremia. At a dose of 9 mg/kg, resultant penetration of 5% was higher than in previous reports, more consistent with inflamed meninges. CONCLUSIONS: High-dose daptomycin may be an alternative option for MSSA bacteremia with or without a CNS source in patients who have failed or cannot tolerate standard therapy. Further clinical evaluation in patients with confirmed meningitis is warranted.


Subject(s)
Anti-Bacterial Agents/cerebrospinal fluid , Daptomycin/cerebrospinal fluid , Meningitis, Bacterial/drug therapy , Staphylococcal Infections/drug therapy , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Daptomycin/blood , Daptomycin/therapeutic use , Humans , Male , Meningitis, Bacterial/microbiology , Methicillin/pharmacology , Middle Aged , Nafcillin/adverse effects , Nephritis, Interstitial/chemically induced , Recurrence , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
6.
J Pain Res ; 3: 67-79, 2010 May 25.
Article in English | MEDLINE | ID: mdl-21197311

ABSTRACT

This paper reviews the current data on the use of the first approved intravenous ibuprofen product for the management of post-operative pain and fever in the United States. The management of acute and post-operative pain and fever with nonsteroidal anti-inflammatory agents (NSAIDs) is well documented. A search in Medline and International Pharmaceutical Abstracts of articles until the end of November 2009 and references of all citations were conducted. Available manufacturer data on file were also analyzed for this report. Several randomized controlled studies have demonstrated the opioid-sparing and analgesic effects of 400 and 800 mg doses of intravenous ibuprofen in a series of post-operative patient populations. Two recent studies have also noted the improvement in fever curves in critically ill and burn patients. These data, along with pharmacokinetic and pharmacologic properties, are explored in this review, which addresses the clinical utility of a parenteral NSAID in a hospitalized patient for post-operative pain management and fever reduction. Further data on intravenous ibuprofen are needed to define long-term utilization, management of acute pain, and use in special populations.

7.
Clin Pharmacol ; 2: 143-8, 2010.
Article in English | MEDLINE | ID: mdl-22291498

ABSTRACT

INTRODUCTION: Hospital patients recovering from critical illness on general floors often receive insulin therapy based on protocols designed for patients admitted directly to general floors. The objective of this study is to compare glycemic control and insulin dosing in patients recovering from critical illness and those without prior critical illness. METHODS: Medical record review of blood glucose measurements and insulin dosing in 25 patients under general ward care while transitioning from the intensive care unit (transition group) and 25 patients admitted directly to the floor (direct floor group). RESULTS: Average blood glucose did not differ significantly between groups (transition group 9.49 mmol/L, direct floor group 9.6 mmol/L; P = 0.83). Significant differences in insulin requirements were observed between groups with average daily doses of 55.9 units in patients transitioning from the intensive care unit (ICU) versus 25.6 units in the direct floor group (P = 0.004). CONCLUSIONS: Patients recovering from critical illness required significantly larger doses of insulin than those patients admitted directly to the floor. Managing insulin therapy in patients transitioning from the ICU may require greater insulin doses.

8.
South Med J ; 102(4): 438-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19279530

ABSTRACT

A 38-year-old African-American male complaining of pain in multiple joints was initially diagnosed with gouty arthritis concurrent with gonococcal septic arthritis. The diagnosis was made based on arthrocentesis results showing Gram-variable cocci and monosodium urate crystals in the synovial fluid. Final blood and synovial fluid cultures confirmed a diagnosis of primary septic arthritis caused by Neisseria meningitidis, serogroup X. Further evaluation revealed a reactive HIV antibody test with enzyme- linked immunoassay (ELISA) confirmed by western blot. His CD4 count was 36 cells/mm and viral load was >500,000 copies/mL. We present a case of primary meningococcal arthritis caused by N meningitidis serogroup X as the initial presentation of a patient with previously undiagnosed HIV.


Subject(s)
Arthritis, Infectious/diagnosis , HIV Infections/diagnosis , Meningococcal Infections/diagnosis , Adult , Arthritis, Infectious/drug therapy , Arthritis, Infectious/microbiology , Blotting, Western , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Humans , Male , Meningococcal Infections/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...